DK1799201T3 - 4-Hydroxy-tamoxifen gelformuleringer - Google Patents

4-Hydroxy-tamoxifen gelformuleringer

Info

Publication number
DK1799201T3
DK1799201T3 DK05803579T DK05803579T DK1799201T3 DK 1799201 T3 DK1799201 T3 DK 1799201T3 DK 05803579 T DK05803579 T DK 05803579T DK 05803579 T DK05803579 T DK 05803579T DK 1799201 T3 DK1799201 T3 DK 1799201T3
Authority
DK
Denmark
Prior art keywords
hydroxy
gel formulations
tamoxifen gel
tamoxifen
formulations
Prior art date
Application number
DK05803579T
Other languages
English (en)
Inventor
Valerie Masini-Eteve
Original Assignee
Besins Int Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from EP04292447A external-priority patent/EP1647271A1/en
Application filed by Besins Int Lab filed Critical Besins Int Lab
Application granted granted Critical
Publication of DK1799201T3 publication Critical patent/DK1799201T3/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0041Mammary glands, e.g. breasts, udder; Intramammary administration
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/13Amines
    • A61K31/135Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/138Aryloxyalkylamines, e.g. propranolol, tamoxifen, phenoxybenzamine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0014Skin, i.e. galenical aspects of topical compositions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/06Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/14Drugs for genital or sexual disorders; Contraceptives for lactation disorders, e.g. galactorrhoea
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/02Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/24Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/32Antioestrogens
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38Cellulose; Derivatives thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dermatology (AREA)
  • Endocrinology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Reproductive Health (AREA)
  • Diabetes (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Cosmetics (AREA)
DK05803579T 2004-10-14 2005-10-13 4-Hydroxy-tamoxifen gelformuleringer DK1799201T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP04292447A EP1647271A1 (en) 2004-10-14 2004-10-14 4-Hydroxy tamoxifen gel formulations
US63835904P 2004-12-23 2004-12-23
PCT/EP2005/011654 WO2006040196A1 (en) 2004-10-14 2005-10-13 4-hydroxy tamoxifen gel formulations

Publications (1)

Publication Number Publication Date
DK1799201T3 true DK1799201T3 (da) 2009-03-30

Family

ID=35501209

Family Applications (1)

Application Number Title Priority Date Filing Date
DK05803579T DK1799201T3 (da) 2004-10-14 2005-10-13 4-Hydroxy-tamoxifen gelformuleringer

Country Status (23)

Country Link
EP (1) EP1799201B1 (da)
JP (1) JP5047800B2 (da)
KR (1) KR101294947B1 (da)
AT (1) ATE415156T1 (da)
AU (1) AU2005293712B2 (da)
BR (1) BRPI0518139B1 (da)
CA (1) CA2582174C (da)
CY (1) CY1110499T1 (da)
DE (1) DE602005011314D1 (da)
DK (1) DK1799201T3 (da)
EA (1) EA011295B1 (da)
ES (1) ES2318563T3 (da)
GE (1) GEP20104889B (da)
HR (1) HRP20090239T1 (da)
IL (1) IL182298A (da)
MA (1) MA28927B1 (da)
MX (1) MX2007004371A (da)
NO (1) NO338755B1 (da)
PL (1) PL1799201T3 (da)
PT (1) PT1799201E (da)
SI (1) SI1799201T1 (da)
TN (1) TNSN07139A1 (da)
WO (1) WO2006040196A1 (da)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10080760B2 (en) * 2009-10-27 2018-09-25 Besins Healthcare Luxembourg Sarl Transdermal pharmaceutical compositions comprising active agents
KR101304536B1 (ko) * 2011-06-03 2013-09-24 전남대학교산학협력단 4-하이드록시 타목시펜 유사체 또는 이의 약학적으로 허용 가능한 염을 유효성분으로 포함하는 간질환의 치료 또는 예방용 조성물

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2558373B1 (fr) * 1984-01-20 1987-07-03 Mauvais Jarvis Pierre Medicament antioestrogene a base de 4-hydroxytamoxifene pour administration percutanee
WO2004054557A2 (en) * 2002-12-18 2004-07-01 Laboratoires Besins International Treatment of mastalgia with 4-hydroxy tamoxifen
JP4684655B2 (ja) * 2002-12-18 2011-05-18 ラボラトワール ブザン アンテルナスィヨナル 4−ヒドロキシタモキシフェンによる乳房密度低下
CA2519980C (en) * 2003-04-01 2012-04-10 Laboratoires Besins International Prevention and treatment of breast cancer with 4-hydroxy tamoxifen
PL1694319T3 (pl) * 2003-12-15 2009-01-30 Besins Healthcare Lu Sarl Zastosowanie 4-hydroksytamoksyfenu do wytwarzania leku do leczenia ginekomastii
CN1946387B (zh) * 2004-03-22 2011-08-31 法国法杏大药厂 4-羟基三苯氧胺在制备治疗和预防良性乳房疾病的药物中的应用
EP1579857A1 (en) * 2004-03-22 2005-09-28 Laboratoires Besins International Chemically stable compositions of 4-hydroxy tamoxifen
EP1579856A1 (en) * 2004-03-22 2005-09-28 Laboratoires Besins International Treatment and prevention of benign breast disease with 4-hydroxy tamoxifen

Also Published As

Publication number Publication date
EP1799201B1 (en) 2008-11-26
KR101294947B1 (ko) 2013-08-09
WO2006040196A1 (en) 2006-04-20
ATE415156T1 (de) 2008-12-15
BRPI0518139A (pt) 2008-10-28
AU2005293712A1 (en) 2006-04-20
PL1799201T3 (pl) 2009-05-29
CA2582174A1 (en) 2006-04-20
EA200700834A1 (ru) 2007-10-26
TNSN07139A1 (en) 2008-11-21
EP1799201A1 (en) 2007-06-27
IL182298A (en) 2013-01-31
EA011295B1 (ru) 2009-02-27
DE602005011314D1 (de) 2009-01-08
SI1799201T1 (sl) 2009-06-30
BRPI0518139B1 (pt) 2021-10-13
CA2582174C (en) 2013-01-29
JP5047800B2 (ja) 2012-10-10
MX2007004371A (es) 2007-06-07
NO20072463L (no) 2007-05-14
HK1103027A1 (en) 2007-12-14
PT1799201E (pt) 2009-02-26
IL182298A0 (en) 2007-07-24
NO338755B1 (no) 2016-10-17
ES2318563T3 (es) 2009-05-01
KR20070068366A (ko) 2007-06-29
CY1110499T1 (el) 2015-04-29
JP2008525316A (ja) 2008-07-17
GEP20104889B (en) 2010-02-10
AU2005293712B2 (en) 2011-04-21
MA28927B1 (fr) 2007-10-01
HRP20090239T1 (en) 2009-06-30

Similar Documents

Publication Publication Date Title
NO20091976L (no) Nye forbindelser
SE0301653D0 (sv) Novel compounds
DE602005014628D1 (de) Embolie-teilchen
IL249263A0 (en) Methods and systems for extracorporeal organ treatment
ATE528989T1 (de) Kristalline feste rasagilin-base
DK2046820T3 (da) Muteiner af tåre-lipocalin og fremgangsmåder til opnåelse deraf
BR122018009866B8 (pt) métodos para preparar compostos de éter aminocicloexílico e compostos intermediários
EP1423137A4 (en) Lipopeptide stereoisomers, methods for preparing same, and useful intermediates
ITMI20030385A1 (it) Composizione cosmetica comprendente poliisoprene.
UA87335C2 (en) Gel composition of 4-hydroxytamoxifen
NO20063393L (no) Farmasoytiske preparater
BRPI0417205A (pt) composições farmacêuticas
EA200601596A1 (ru) Улучшенный состав 6-меркаптопурина
TNSN07139A1 (en) 4-hydroxy tamoxifen gel formulations
MX2007002917A (es) Todo-trans-retinol: todo-trans-13, 14-dihidrorretinol saturasa y metodos de uso de la misma.
ATE542796T1 (de) N-sulfonylcarboximidamidverbindungen als apoptosepromotoren
DE602005009681D1 (de) Haarbehandlungszusammensetzungen mit einem disaccharid; einer disäure und einer ammoniumionen-quelle
EA200700023A1 (ru) Разрыхляющаяся при пероральном приёме фармацевтическая композиция, содержащая рисперидон
EA200700580A1 (ru) Тестостероновые гели, включающие пропиленгликоль в качестве усилителя проницаемости
ATE425212T1 (de) Tocopherolzusammensetzungen und verwendung
ITMI20040146A1 (it) Ibopamina maleato metodo per prepararlo e composizioni farmaceutiche che lo comprendono
EA200701201A1 (ru) Новая фармацевтическая композиция для вакцин
ITRM20020358A0 (it) Composizione estetico-farmaceutica per applicazione topica, procedimento per la sua produzione e suoi impieghi.
BRPI0501052A (pt) composição cosmética à base de papaìna
BRPI0502164A (pt) Composição cosmética à base de bromelina